GO-203

Catalog No.S8674 Batch:S867401

Print

Technical Data

Formula

C87H170N52O19S2.C2HF3O2
Molecular Weight 2426.77 CAS No. 1222186-26-6
Solubility (25°C)* In vitro Water 100 mg/mL (41.2 mM)
 
 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description GO-203 is a D-amino acid cell-penetrating peptide inhibitor of MUC1-C dimerization and thereby its oncogenic function.
Targets
MUC-1C [1]
In vitro GO-203 inhibits MUC1-C homodimerization which blocks its oncogenic function. Treatment of MUC1-overexpressing SKCO-1 and Colo-205 colon cancer cells with GO-203 is associated with downregulation of the TP53-inducible glycolysis and apoptosis regulator (TIGAR) protein. GO-203 regulates AKT-S6K1-elF4A signaling in colorectal cancer cells. Targeting MUC1-C with GO-203 inhibits p-AKT in colorectal cancer cells. GO-203 treatment also results in increases in reactive oxygen species (ROS) and loss of mitochondrial transmembrane potential[1].
In vivo GO-203 is effective in inhibiting growth and survival of MUC1-positive colorectal cancer cells in mouse xenograft models. It is also effective in xenografts models of breast, prostate, lung and certain hematologic malignancy[1].

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    Human SW480 and LOVO colorectal cancer cells

  • Concentrations

    5 μM

  • Incubation Time

    48 h

  • Method

    To assess cell viability, 20,000–30,000 cells are plated and cultured for 48 h. GO-203 and CP-2 are added at 5 μM every day for six days. Cell viability is measured by trypan blue exclusion.
Animal Study:

[1]
  • Animal Models

    BALB/c nu/nu male/female mice with xenograft tumor

  • Dosages

    18 mg/kg

  • Administration

    i.p.

Selleck's GO-203 has been cited by 5 publications

Dexamethasone Selectively Inhibits Detachment of Metastatic Thyroid Cancer Cells during Random Positioning [ Cancers (Basel), 2023, 15(6)1641] PubMed: 36980530
Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway [ Nat Cell Biol, 2022, 24(3):364-372] PubMed: 35292781
Mucin 1 Inhibits Ferroptosis and Sensitizes Vitamin E to Alleviate Sepsis-Induced Acute Lung Injury through GSK3β/Keap1-Nrf2-GPX4 Pathway [ Oxid Med Cell Longev, 2022, 2022:2405943] PubMed: 35910848
Protective and predictive role of Mucin1 in sepsis-induced ALI/ARDS. [ Int Immunopharmacol, 2020, 1;83:106438] PubMed: 32247267
Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4/NF-κB pathway. [ Drug Des Devel Ther, 2019, 13:3391-3404] PubMed: 31576113

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.